1279 related articles for article (PubMed ID: 17200307)
1. Factors associated with prolonged wound drainage after primary total hip and knee arthroplasty.
Patel VP; Walsh M; Sehgal B; Preston C; DeWal H; Di Cesare PE
J Bone Joint Surg Am; 2007 Jan; 89(1):33-8. PubMed ID: 17200307
[TBL] [Abstract][Full Text] [Related]
2. Wound complications following rivaroxaban administration: a multicenter comparison with low-molecular-weight heparins for thromboprophylaxis in lower limb arthroplasty.
Jameson SS; Rymaszewska M; Hui AC; James P; Serrano-Pedraza I; Muller SD
J Bone Joint Surg Am; 2012 Sep; 94(17):1554-8. PubMed ID: 22832942
[TBL] [Abstract][Full Text] [Related]
3. Multimodal thromboprophylaxis for total hip and knee arthroplasty based on risk assessment.
Dorr LD; Gendelman V; Maheshwari AV; Boutary M; Wan Z; Long WT
J Bone Joint Surg Am; 2007 Dec; 89(12):2648-57. PubMed ID: 18056497
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Surgical Site Infection Risk Between Warfarin, LMWH, and Aspirin for Venous Thromboprophylaxis in TKA or THA: A Systematic Review and Meta-Analysis.
Hughes LD; Lum J; Mahfoud Z; Malik RA; Anand A; Charalambous CP
JBJS Rev; 2020 Dec; 8(12):e20.00021. PubMed ID: 33347014
[TBL] [Abstract][Full Text] [Related]
5. Impact of perioperative allogeneic and autologous blood transfusion on acute wound infection following total knee and total hip arthroplasty.
Newman ET; Watters TS; Lewis JS; Jennings JM; Wellman SS; Attarian DE; Grant SA; Green CL; Vail TP; Bolognesi MP
J Bone Joint Surg Am; 2014 Feb; 96(4):279-84. PubMed ID: 24553883
[TBL] [Abstract][Full Text] [Related]
6. Is Enoxaparin Associated With a Higher Risk of Persistent Wound Drainage Than Aspirin? A Secondary Analysis of Data From the CRISTAL Randomized Trial.
Sidhu VS; Naylor JM; Adie S; Lieu D; Walker R; Horsley M; Kim RG; Harris IA
Clin Orthop Relat Res; 2023 Jul; 481(7):1351-1359. PubMed ID: 36649465
[TBL] [Abstract][Full Text] [Related]
7. [A prospective randomized study of wound drainage versus non-drainage in primary total hip or knee arthroplasty].
Mengal B; Aebi J; Rodriguez A; Lemaire R
Rev Chir Orthop Reparatrice Appar Mot; 2001 Feb; 87(1):29-39. PubMed ID: 11240535
[TBL] [Abstract][Full Text] [Related]
8. Blood transfusion in primary total hip and knee arthroplasty. Incidence, risk factors, and thirty-day complication rates.
Hart A; Khalil JA; Carli A; Huk O; Zukor D; Antoniou J
J Bone Joint Surg Am; 2014 Dec; 96(23):1945-51. PubMed ID: 25471908
[TBL] [Abstract][Full Text] [Related]
9. Cost implications of low molecular weight heparins as prophylaxis following total hip and knee replacement.
Bell GK; Goldhaber SZ
Vasc Med; 2001; 6(1):23-9. PubMed ID: 11358156
[TBL] [Abstract][Full Text] [Related]
10. Comorbidities and perioperative complications in HIV-positive patients undergoing primary total hip and knee arthroplasty.
Lin CA; Kuo AC; Takemoto S
J Bone Joint Surg Am; 2013 Jun; 95(11):1028-36. PubMed ID: 23780541
[TBL] [Abstract][Full Text] [Related]
11. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
Míka P; Behounek J; Skoták M; Nevsímal L
Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
[TBL] [Abstract][Full Text] [Related]
12. Extended-duration low-molecular-weight heparin prophylaxis following total joint arthroplasty.
Whang PG; Lieberman JR
Am J Orthop (Belle Mead NJ); 2002 Sep; 31(9 Suppl):31-6. PubMed ID: 12349893
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for pulmonary embolism and the effects of fondaparinux after total hip and knee arthroplasty: a retrospective observational study with use of a national database in Japan.
Nagase Y; Yasunaga H; Horiguchi H; Hashimoto H; Shoda N; Kadono Y; Matsuda S; Nakamura K; Tanaka S
J Bone Joint Surg Am; 2011 Dec; 93(24):e146. PubMed ID: 22258781
[TBL] [Abstract][Full Text] [Related]
14. The Effect of Smoking on Short-Term Complications Following Total Hip and Knee Arthroplasty.
Duchman KR; Gao Y; Pugely AJ; Martin CT; Noiseux NO; Callaghan JJ
J Bone Joint Surg Am; 2015 Jul; 97(13):1049-58. PubMed ID: 26135071
[TBL] [Abstract][Full Text] [Related]
15. No Increased Risk of Venous Thromboembolism in High-Risk Patients Continuing Their Dose of 75 mg Aspirin Compared to Healthier Patients Given Low-Molecular-Weight Heparin.
Hovik O; Amlie EJ; Jenssen KK
J Arthroplasty; 2021 Oct; 36(10):3589-3592. PubMed ID: 34176693
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of thromboprophylaxis with low-molecular-weight heparin or rivaroxaban in hip and knee replacement surgery: findings from the ORTHO-TEP registry.
Beyer-Westendorf J; Lützner J; Donath L; Tittl L; Knoth H; Radke OC; Kuhlisch E; Stange T; Hartmann A; Günther KP; Weiss N; Werth S
Thromb Haemost; 2013 Jan; 109(1):154-63. PubMed ID: 23197272
[TBL] [Abstract][Full Text] [Related]
17. Incisional Negative Pressure Wound Therapy Devices Improve Short-Term Wound Complications, but Not Long-Term Infection Rate Following Hip and Knee Arthroplasty.
Keeney JA; Cook JL; Clawson SW; Aggarwal A; Stannard JP
J Arthroplasty; 2019 Apr; 34(4):723-728. PubMed ID: 30612833
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of prophylaxis against thromboembolism with intermittent pneumatic compression after primary and revision total hip arthroplasty.
Hooker JA; Lachiewicz PF; Kelley SS
J Bone Joint Surg Am; 1999 May; 81(5):690-6. PubMed ID: 10360697
[TBL] [Abstract][Full Text] [Related]
19. Surgical treatment of early wound complications following primary total knee arthroplasty.
Galat DD; McGovern SC; Larson DR; Harrington JR; Hanssen AD; Clarke HD
J Bone Joint Surg Am; 2009 Jan; 91(1):48-54. PubMed ID: 19122078
[TBL] [Abstract][Full Text] [Related]
20. Prevention of venous thromboembolic disease after total hip and knee arthroplasty.
Lieberman JR; Hsu WK
J Bone Joint Surg Am; 2005 Sep; 87(9):2097-112. PubMed ID: 16140827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
